Guifang Ouyang - Publications, H-index & Citations

Guifang Ouyang

The First Affiliated Hospital of Ningbo University

2H指数

19论文数

8被引数

收录论文 11

发表时间

CSF ctDNA Molecular Clearance as a Prognostic Biomarker for Orelabrutinib-Treated Primary Central Nervous System Lymphoma: Insights From Comparison With PET-CT 脑脊液ctDNA分子清除作为奥雷巴替尼治疗原发性中枢神经系统淋巴瘤的预后生物标志物：与PET-CT比较的见解

American Journal of Hematology

IF9.9

2026-07-28

PREAI

Lixia Sheng; Huijie Hu; Yanli Lai; Shuyan Wang; Di Wang; Shanhao Tang; Kaihong Xu; Yongcheng Sun; Ping Zhang; Binbin Lai; Li Hu; Lieguang Chen; Yuning Pan; Sheng Nie; Xiang Gao; Lei Fan; Guifang Ouyang

Torque Teno Virus Drives Atypical Acute Promyelocytic Leukemia as a Novel Molecular Subtype Torque Teno病毒驱动一种新型分子亚型的非典型急性早幼粒细胞白血病

American Journal of Hematology

IF9.9

2026-03-07

PREAI

Xiaosu Zhou; Qitian Mu; Hongwei Chen; Ying Chen; Haiyang Wang; Yang Zhang; Panxiang Cao; Xiaoli Ma; Jiaqi Chen; Xue Chen; Jiancheng Fang; Guifang Ouyang; Qihui Chen; Haibo Sun; Xiujuan Ma; Fang Wang; Zhanglin Zhang; Jianhong Zhao; Hongxing Liu

Establishment of closed dumbbell mediated isothermal amplification assay for rapid and simple detection of Streptococcus agalactiae (GBS)建立闭式哑铃介导的等温扩增检测方法，用于快速、简便地检测Streptococcus agalactiae (GBS)

Microchemical Journal

IF5.1

2026-03-03

PREAI

Yanli Zhang; Xuhan Chen; Yeling Zhong; Fei Guo; Yonghua Chen; Guifang Ouyang; Rui Mao

A ROS-Responsive Dimeric Prodrug Nanoassembly for Amplified Epigenetic Therapy of Lymphoma 一种响应ROS的二聚前药纳米组装体，用于放大淋巴瘤的表观遗传治疗

Journal of Medicinal Chemistry

IF6.8

2026-03-01

PREAI

Tongyu Li; Wanchuan Zhuang; Shufang Fan; Ping Yi; Lixia Sheng; Wenbin Qian; Guifang Ouyang

Optimization of loop-mediated isothermal amplification harnessing a novel primer design targeting at short DNA sequence

Microchemical Journal

IF5.1

2026-01-22

PREAI

Yanli Zhang; Guifang Ouyang; Dingcheng Zheng; Xuhan Chen; Rui Mao

Validation of risk stratification and novel prognostic biomarkers in asian adult HSCT recipients with TA-TMA: A multicenter real-world study 亚洲成人HSCT受者TA-TMA风险分层和新预后生物标志物的验证：一项多中心真实世界研究

Bone Marrow Transplantation

IF5.2

2026-01-09

PREAI

Yibo Wu; Xiaolin Yuan; Lieguang Chen; Xiaoyu Lai; Lizhen Liu; Luxin Yang; Jimin Shi; Jian Yu; Yanmin Zhao; Guifang Ouyang; Lihong Ni; Haowen Xiao; Yang Xu; Li Tang; Panpan Zhu; Zhen Cai; He Huang; Ying Lu; Yi Luo

Esterase-Activatable Dimeric HDAC Inhibitor Nanotherapeutics for Enhanced Lymphoma Epigenetic Therapy 酯酶激活的二聚体HDAC抑制剂纳米治疗剂用于增强淋巴瘤表观遗传治疗

Colloids and Surfaces B: Biointerfaces

IF5.6

2026-01-08

PREAI

Tongyu Li; Wanchuan Zhuang; Shufang Fan; Ping Yi; Guifang Ouyang; Wenbin Qian

NUP98 rearrangement dynamics predict outcomes in adult patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation: a multicenter real-world study NUP98重排动力学可预测接受allo-HSCT治疗的急性髓系白血病成年患者结局：一项多中心真实世界研究

Transplantation and Cellular Therapy

IF4.4

2025-08-05

PREAI

Xiaolin Yuan; Lihong Ni; Ting Chen; Yibo Wu; Xiaoyu Lai; Lizhen Liu; Zhengli Xu; Yajing Xu; Tingting Yang; Ying Lu; Weijie Cao; Yi Chen; Kourong Miao; Guifang Ouyang; Luxin Yang; Xi Zhang; Yu Wang; Yi Luo

Impact of Decitabine Conditioning on Allo-HSCT Outcomes in AML and Intermediate-to-High-Risk MDS Patients in Remission 去甲基胞苷预处理对处于缓解期的急性髓系白血病和中危至高危骨髓增生异常综合征患者异基因造血干细胞移植结局的影响

Cancer Medicine

IF3.1

2025-07-23